Kexing Biopharm Revenue

In the year 2025, Kexing Biopharm had annual revenue of 1.53B CNY with 9.03% growth. Kexing Biopharm had revenue of 386.39M in the quarter ending December 31, 2025, with 4.81% growth.

Revenue

1.53B

Revenue Growth

+9.03%

P/S Ratio

3.51

Revenue / Employee

1.54M

Employees

971

Market Cap

5.13B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.53B	127.10M	9.03%
Dec 31, 2024	1.41B	147.89M	11.75%
Dec 31, 2023	1.26B	-56.84M	-4.32%
Dec 31, 2022	1.32B	30.70M	2.39%
Dec 31, 2021	1.29B	64.88M	5.32%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Wuhan Hvsen Biotechnology	1.68B
Beijing Konruns Pharmaceutical	917.99M
Shouyao Holdings (Beijing) Co., LTD.	34.67M
Shenzhen Weiguang Biological Products	1.26B
Novogene	2.26B
PharmaResources (Shanghai)	667.47M
Lifecome Biochemistry	502.95M
Hangzhou Biotest Biotech	449.50M

Revenue Rankings